What is Ansa Biotechnologies worth?
$269.0Mlast known valuation
Ansa Biotechnologies last raised $46.4M in its Early Stage VC (Jun 2024).
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 27 names
- ·Watchlist + deal alerts for Ansa Biotechnologies
Create free account
No card required
Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jun 2024 | Early Stage VC | $46.4M | ▮ | ▮ |
| Apr 2022 | Early Stage VC (Series A) | $68.0M | ▮ | ▮ |
| Oct 2021 | Early Stage VC | $5.0M | ▮ | ▮ |
| Jun 2020 | Seed Round | $4.7M | ▮ | ▮ |
How Ansa Biotechnologies's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Ansa Biotechnologies, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Ansa Biotechnologies worth?
- Ansa Biotechnologies's last known valuation is $269.0M.
- How much has Ansa Biotechnologies raised?
- Ansa Biotechnologies has raised $139.6M in total funding across 4 recorded rounds.
- When did Ansa Biotechnologies last raise?
- Ansa Biotechnologies last raised in Jun 2024 (Early Stage VC), raising $46.4M.